These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1153462)

  • 1. The effect of BCNU, CCNU and MeCCNU in the prevention of the development of tumors of the nervous system.
    Pezzotta S; Agradi E; Paoletti P
    Pharmacol Res Commun; 1975 Feb; 07(1):49-53. PubMed ID: 1153462
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic effects of some alkylating derivatives of nitrosourea on the development of tumors transplacentally induced in rats by ENU.
    Schiffer D; Giordana MT; Pezzotta S; Paoletti P
    Acta Neuropathol; 1976 Jan; 34(1):21-31. PubMed ID: 175631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy studies of various nitrosoureas: prevention of development of ethylnitrosourea-induced tumors in the nervous system.
    Paoletti P; Giordana MT; Pezzotta S; Schiffer D
    Natl Cancer Inst Monogr; 1977 Dec; 46():161-2. PubMed ID: 613226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
    Zeller WJ; Eisenbrand G; Fiebig HH
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant nitrosourea therapy for glioblastoma.
    Brisman R; Housepian EM; Chang C; Duffy P; Balis E
    Arch Neurol; 1976 Nov; 33(11):745-50. PubMed ID: 985152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
    Stephens TC; Adams K; Peacock JH
    Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.
    Walker MD; Green SB; Byar DP; Alexander E; Batzdorf U; Brooks WH; Hunt WE; MacCarty CS; Mahaley MS; Mealey J; Owens G; Ransohoff J; Robertson JT; Shapiro WR; Smith KR; Wilson CB; Strike TA
    N Engl J Med; 1980 Dec; 303(23):1323-9. PubMed ID: 7001230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of nitrosourea compounds in cancer chemotherapy].
    Robak T
    Pol Tyg Lek; 1982 Sep; 37(36):1067-70. PubMed ID: 6763214
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center.
    Chin HW; Young AB; Maruyama Y
    Cancer Treat Rep; 1981; 65(1-2):45-51. PubMed ID: 7013978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the CCNU and BCNU modification of the in vitro radiation response in 9L brain tumor cells of rats.
    Deen DF; Williams ME; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1541-4. PubMed ID: 536259
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant chemotherapy with nitrosourea compounds following surgery plus radiotherapy in glioblastoma multiforme.
    Monfardini S; Brambilla C; Solero CL; Vaghi A; Valagussa P; Morello G; Bonadonna G
    Recent Results Cancer Res; 1978; 68():393-8. PubMed ID: 223206
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental chemical production of brain tumors.
    Zeller WJ; Ivankovic S; Habs M; Schmähl D
    Ann N Y Acad Sci; 1982; 381():250-63. PubMed ID: 6953793
    [No Abstract]   [Full Text] [Related]  

  • 14. Nitrosourea chemotherapy for primary malignant gliomas.
    Levin VA; Wilson CB
    Cancer Treat Rep; 1976 Jun; 60(6):719-24. PubMed ID: 954010
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
    Teicher BA; Holden SA; Rose CM
    Int J Cancer; 1986 Aug; 38(2):285-8. PubMed ID: 3089945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.
    Osieka R; Glatte P; Pannenbäcker R; Schmidt CG
    Cancer Chemother Pharmacol; 1983; 11(3):147-52. PubMed ID: 6227420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure rates and tumor resistance in cured mice after nitrosourea treatment of EMT6 ascites tumors.
    Feola JM; Maruyama Y
    Oncology; 1986; 43(6):372-7. PubMed ID: 2949185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of the nitrosoureas.
    Wasserman TH; Slavik M; Carter SK
    Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for known residual disease after resection of gastric and colorectal cancer.
    Giles GR; Lawton JO
    Recent Results Cancer Res; 1978; 68():212-6. PubMed ID: 752858
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.